Latest News
FedEx Corp. (NYSE:FDX) Shows Technical Strength and Bullish Setup for Potential Breakoutchartmill.com
Via Chartmill · March 5, 2026
It'll be business as usual for these seniors this tax season.
Via The Motley Fool · March 5, 2026
Via Talk Markets · March 5, 2026
Via Talk Markets · March 5, 2026
Mexico travel fears may fade, leaving this resilient dividend stock poised for long-term gains.
Via The Motley Fool · March 5, 2026
Via Talk Markets · March 5, 2026
Analog Devices Inc. (NASDAQ:ADI) Combines Accelerating Growth with Bullish Technical Setupchartmill.com
Via Chartmill · March 5, 2026
Eric Trump said the big U.S. banks like JPMorgan Chase and Bank of America were acting “anti-retail, anti-consumer and straight-up anti-American” in their efforts to ban stablecoin rewards.
Via Stocktwits · March 5, 2026
Behind every microchip, there's a power cord and a fan.
Via The Motley Fool · March 5, 2026
Applying Peter Lynch's GARP Strategy to Newmont Corp (NYSE:NEM)chartmill.com
Via Chartmill · March 5, 2026
Via Talk Markets · March 5, 2026
VENTAS INC (NYSE:VTR) Presents a Compelling Blend of Earnings Momentum and Technical Strengthchartmill.com
Via Chartmill · March 5, 2026
Via Talk Markets · March 5, 2026
PLTR shares have ended in the green for six straight sessions, rising by over 13%; they dropped marginally in Thursday's premarket.
Via Stocktwits · March 5, 2026
CEO Jeffrey Terry Green bought 6 million shares earlier this week after the stock had been sliding steadily for the past six months.
Via Stocktwits · March 5, 2026
Traders at large remain cautiously optimistic about Nvidia even though its blowout Q4 report failed to save the stock from a sharp decline.
Via Stocktwits · March 5, 2026
There's reason to be optimistic about Nvidia's earnings potential.
Via The Motley Fool · March 5, 2026
Via Talk Markets · March 5, 2026
Via Talk Markets · March 5, 2026

PepGen (PEPG) shifts focus to DM1 but faces a fresh FDA roadblock. Clinical data, analyst ratings, and technical support levels inside.
Via Benzinga · March 5, 2026

Ayatollah Ali Khamenei's son, Mojtaba Khamenei, could be the next Supreme Leader of Iran. His rise would be historic and controversial.
Via Benzinga · March 5, 2026
A quarter of Alphabet's nearly $2.6 billion investment portfolio is comprised of a space stock with the potential to deliver eye-popping sales growth.
Via The Motley Fool · March 5, 2026
Both restaurant chains have had challenging years.
Via The Motley Fool · March 5, 2026
Via Talk Markets · March 5, 2026
PACIRA BIOSCIENCES INC (NASDAQ:PCRX) Presents a Compelling Value Investment Casechartmill.com
Via Chartmill · March 5, 2026
Via Talk Markets · March 5, 2026
The cryptocurrency's status as the leader in decentralized finance makes it hard to beat.
Via The Motley Fool · March 5, 2026
Ford's February sales in US decline by 5.5% amid scaling back on EV offerings and an anti-EV market environment.
Via Benzinga · March 5, 2026
Certain Wall Street analysts see substantial upside in Meta Platforms and Atlassian.
Via The Motley Fool · March 5, 2026

Renowned short-seller Jim Chanos has cast doubt on IREN Ltd.'s (NASDAQ:IREN) massive new $6 billion equity filing, questioning the
Via Benzinga · March 5, 2026
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shows Strong Growth and Bullish Chart Setupchartmill.com
Via Chartmill · March 5, 2026
Via Talk Markets · March 5, 2026
Perspective is powerful, even amid heightened uncertainty.
Via The Motley Fool · March 5, 2026
The FDA review of Deramiocel remains ongoing and could eventually lead to the assignment of a new PDUFA decision date.
Via Stocktwits · March 5, 2026

As Luckin Coffee expands overseas, the Chinese coffee company has reportedly bought Blue Bottle from Nestlé.
Via Stocktwits · March 5, 2026
Via Talk Markets · March 5, 2026
Aptiv PLC (NYSE:APTV) Passes the "Caviar Cruise" Test for Quality Investingchartmill.com
Via Chartmill · March 5, 2026
Apple's new $599 MacBook Neo could lift revenue by about 0.5% and strengthen its push into the student market.
Via Benzinga · March 5, 2026
Alibaba stock has lost over 13% in the past week, and is now down 31% from its peak in early October 2025.
Via Stocktwits · March 5, 2026
Niagen Bioscience Inc. surged in after-hours trading after reporting record 2025 results, while maintaining a cautious outlook for 2026.
Via Benzinga · March 5, 2026
These are all helpful things to know before retirement, actually.
Via The Motley Fool · March 5, 2026
